159 filings
8-K
DNLI
Denali Therapeutics Inc
31 May 24
Submission of Matters to a Vote of Security Holders
4:01pm
10-Q
2024 Q1
DNLI
Denali Therapeutics Inc
Quarterly report
7 May 24
4:05pm
8-K
DNLI
Denali Therapeutics Inc
7 May 24
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
4:03pm
ARS
2023 FY
DNLI
Denali Therapeutics Inc
18 Apr 24
Annual report to shareholders
4:05pm
DEFA14A
DNLI
Denali Therapeutics Inc
18 Apr 24
Additional proxy soliciting materials
4:04pm
S-3ASR
i8m0tnpk zkeu732qc
22 Mar 24
Automatic shelf registration
4:01pm
D
544u9z
1 Mar 24
$499.73 mm in equity / options, sold $499.73 mm, 11 investors
4:51pm
S-8
jtw6nh
27 Feb 24
Registration of securities for employees
8:21pm
8-K
rdcbb xoq4z2csbc1ajh
27 Feb 24
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
8:07am
8-K
kqv9n3 wt
27 Feb 24
Denali Therapeutics Announces $500 million Private Placement Equity Financing
8:03am
8-K
4ry55de24b4
16 Feb 24
Regulation FD Disclosure
8:02am
8-K
cky9s3 d2jfplxn8
8 Jan 24
Regulation FD Disclosure
8:06am
8-K
0obo yfn24n
7 Nov 23
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
z9n9ke76zyje
21 Aug 23
Entry into a Material Definitive Agreement
4:06pm
8-K
rrb n4k0w024
8 Aug 23
Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
vaufxgez h0vgc
20 Jun 23
Other Events
7:03am